Oxford Biomedica is reviewing its gene therapeutics pipeline to establish capacity requirements at the Windrush Innovation Centre in Oxford. The move comes amid ongoing development of lab space at Oxford Biomedica Solutions in the US as well as potential for
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
Register
Find Out More